Search Results - Desirée Van Oorschot
- Showing 1 - 11 results of 11
-
1
Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany by Desmond Curran, Desirée Van Oorschot, Sean Matthews, Johannes Hain, Ahmed Ehab Salem, Magdalena Schwarz
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
A systematic literature review of herpes zoster incidence worldwide by Désirée van Oorschot, Hilde Vroling, Eveline Bunge, John Diaz-Decaro, Desmond Curran, Barbara Yawn
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older by Makoto Shiragami, Akiko Mizukami, Toshihiko Kaise, Desmond Curran, Desiree Van Oorschot, Benjamin Bracke, Daisuke Watanabe
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Cost effectiveness and budget impact of universal varicella vaccination in Russia by Alen Marijam, Ekaterina Safonova, Mikhail Scherbakov, Evgeniy Shpeer, Desirée Van Oorschot, Alla Rudakova, Vladimir Tatochenko, Nikolay Briko
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Assessment of the potential public health impact of Herpes Zoster vaccination in Germany by Desmond Curran, Desirée Van Oorschot, Lijoy Varghese, Lidia Oostvogels, Tomas Mrkvan, Romulo Colindres, Alfred von Krempelhuber, Anastassia Anastassopoulou
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-suppo... by Alen Marijam, Lode Schuerman, Patricia Izurieta, Priya Pereira, Désirée Van Oorschot, Shailesh Mehta, Martin OC Ota, Baudouin Standaert
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old by Desirée Van Oorschot, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, Lijoy Varghese, Alfred von Krempelhuber, Mohamed Neine, Stéphane Lorenc, Desmond Curran
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
8
Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico by Enrique Chacon-Cruz, Erika Zoe Lopatynsky-Reyes, Gloria Huerta-Garcia, Maria Yolanda Cervantes-Apolinar, Adriana Guzman-Holst, Desiree Van Oorschot
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
9
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live by Desmond Curran, Brandon J. Patterson, Desiree Van Oorschot, Philip O. Buck, Justin Carrico, Katherine A. Hicks, Bruce Lee, Barbara P. Yawn
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
10
Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico by Jorge Gomez, F. Raul Velázquez, Adriana Guzman-Holst, Maria Yolanda Cervantes Apolinar, Laure-Anne Van Bellinghen, Ilse Van Vlaenderen, Désirée van Oorschot
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
11
The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy by Antonio Volpi, Sara Boccalini, Silvia Dari, Christopher Clarke, Desmond Curran, Idalba Loiacono, Andrea Pitrelli, Anna Puggina, Roberta Tosatto, Desirée Van Oorschot, Elisabetta Franco
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book